We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UGPA3:BMFBOVESPAUltrapar Participacoes S.A. Analysis

Data as of 2026-03-15 - not real-time

R$26.12

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Ultrapar (UGPA3) is trading at R$26.12, comfortably above the 20‑day SMA (R$26.66) and well above the 50‑day SMA (R$24.88), confirming a bullish price structure that sits between a clear support at R$24.70 and resistance near R$28. Volume is increasing and the 30‑day volatility of 25% suggests ample price movement potential. The RSI of 50 indicates a neutral momentum, while the MACD histogram is negative, hinting at a short‑term pull‑back within the broader uptrend. Valuation metrics are attractive: a trailing P/E of 11.1 is roughly half the industry average of 22.2, and the price‑to‑book of 1.78 sits below the sector norm, though the DCF‑derived fair value of R$18.2 implies the market is pricing in growth and premium assets. Dividend yield stands at a robust 6.7% with a payout ratio of 74%, supported by solid operating cash flow (R$5.45 bn) and free cash flow (R$1.85 bn).
A material catalyst may emerge from the rumored divestiture of the Ipiranga unit, which analysts argue could unlock hidden value and reshape the fuel‑distribution dynamics. Revenue growth of 7.2% and a ROE of 16% demonstrate steady earnings improvement, yet the company carries a high debt‑to‑equity ratio of 123%, flagging balance‑sheet risk. The low beta of 0.34 points to limited market‑wide volatility, but sector‑specific regulatory and commodity risks remain. Overall, the blend of undervalued multiples, strong dividend income, and a potential strategic sale supports a cautiously optimistic outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish SMA alignment and rising volume
  • High dividend yield providing immediate income
  • Support level at R$24.70 offering downside buffer

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation upside of ~3.5% to analyst target around R$27
  • Projected earnings growth and improving ROE
  • Potential value unlock from Ipiranga sale

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated debt‑to‑equity ratio increasing financial risk
  • Energy sector regulatory and commodity price exposure
  • Sustainable dividend stream offset by balance‑sheet concerns

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin1.72%
P/E Ratio11.1
ROE16.38%
ROA6.95%
Debt/Equity123.14
P/B Ratio1.8
Op. Cash FlowR$5.5B
Free Cash FlowR$1.9B
Industry P/E22.2

Technical Analysis

TrendBullish
RSI50.3
SupportR$24.70
ResistanceR$28.00
MA 20R$26.66
MA 50R$24.88
MA 200R$20.78
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueR$18.21
Target PriceR$27.03
Upside/Downside3.46%
GradeFair
TypeBlend
Dividend Yield6.70%

Risk Assessment

Beta0.34
Volatility25.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.